Lynette Ongeri
Charles River Laboratories (United Kingdom)(GB)
Research Areas
Computational Drug Discovery Methods, Melanoma and MAPK Pathways, 14-3-3 protein interactions
Computational Drug Discovery Methods, Melanoma and MAPK Pathways, 14-3-3 protein interactions